SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-18-301115
Filing Date
2018-10-17
Accepted
2018-10-17 16:46:58
Documents
1
Period of Report
2018-09-26
Items
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A d641791d8ka.htm 8-K/A 17039
  Complete submission text file 0001193125-18-301115.txt   18555
Mailing Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018
Business Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018 (917) 438-4353
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-33958 | Film No.: 181126757
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1